Navigation Links
Mystery E. coli genes essential for survival of many species
Date:7/13/2009

Scientists have shown that E. coli one of the best known and extensively studied organisms in the world remains an enigma that may hold the key to human diseases, such as cancer.

The team, funded by the Biotechnology and Biological Sciences Research Council (BBSRC) and based at the University of Dundee has examined the genome sequence of this workhorse of the laboratory and spotted three previously unknown genes that, it turns out, are essential for the survival of E. coli and one out of the three could also be implicated in cancer or developmental abnormalities in humans. These mystery genes are also found in numerous other creatures, suggesting a vital role for them across many species. The research will be published in the 1 August edition of the Journal of Bacteriology.

The effort over recent years to sequence genomes of various important species has uncovered many previously unknown genes. This has given scientists the opportunity to choose to study these genes now, rather than waiting for them to make themselves known serendipitously e.g. when they are implicated in disease. Professor Tracy Palmer and her colleagues have taken three genes identified through sequencing of the E. coli genome and studied them to discover their significance.

Professor Palmer said: "Scientists have been studying E. coli genes for many, many years and we thought we knew pretty much all there was to know we certainly didn't expect to find any more genes that are essential for survival!

"Finding out that these genes are essential in E. coli and also appear in the genomes of other species tells us that they are very important indeed. In the case of one of the genes it is also found in the human genome, which makes it especially interesting. The mystery remains as to what they actually do, but whatever it is, it must be really crucial.

"Because we now know that one of these genes is found in humans as well, we might be looking at something that is really important in our development or that might cause disease."

Early indications from Professor Palmer's work suggest that the genes, named yjeE, yeaZ and ygjD could be involved in cell division. ygjD is present in the human genome and also appears to be the key player of the three genes found in E. coli.

Professor Palmer continued: "We've done experiments that show these genes affect how E. coli cells respond to different messages that tell them when to divide. If they do the same thing in humans then any problems with these genes could easily lead to developmental abnormalities or cancer."

Professor Douglas Kell, BBSRC Chief Executive said: "This work is a good example of where having a genome sequence opens up many possible avenues of enquiry. It also makes clear the value of an organised approach to accessing and using genome information. Research focussed on maximising the use of genome sequences will surely, therefore, accelerate discovery of information that is of social and economic importance. BBSRC has committed to such activity through the launch of our new Genome Analysis Centre earlier this month."


'/>"/>

Contact: Nancy Mendoza
press.office@bbsrc.ac.uk
44-179-341-3355
Biotechnology and Biological Sciences Research Council
Source:Eurekalert

Related biology news :

1. Mystery of bat with an extraordinary nose solved
2. Harvard scientists solve mystery about why HIV patients are more susceptible to TB infection
3. Scientists tackle the mystery of white-nose syndrome in bats
4. Scientists unravel the mystery of white-nose syndrome
5. Research team wins funds to unravel a DNA mystery
6. Genetic sleuth solves glaucoma mystery
7. Life secret exposed: Scientists unlock mystery of molecular machine
8. Biologists solve mystery of black wolves
9. Fishdunnit! Mystery solved
10. Fish guts explain marine carbon cycle mystery
11. Peering inside the skull of a mouse to solve meningitis mystery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2016)... The Department of Transport Management (DOTM) ... million US Dollar project, for the , Supply ... Enrolment, and IT Infrastructure , to ... implementation of Identity Management Solutions. Numerous renowned international vendors participated ... was selected for the most compliant and innovative ...
(Date:5/24/2016)... IRVINE, Calif. , May 24, 2016 Ampronix facilitates superior patient care ... LMD3251MT  3D medical LCD display is the latest premium product recently added to ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/9/2016)... Elevay is currently known as ... for high net worth professionals seeking travel for work ... world, there is still no substitute for a face-to-face ... your deal with a firm handshake. This is why ... of citizenship via investment programs like those offered by ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... CLEVELAND , June 27, 2016  Global ... average 4.6 percent through 2020 to $7.2 billion.  ... (food and beverages, cleaning products, biofuel production, animal ... and biotechnology, diagnostics, and biocatalysts). Food and beverages ... gains driven by increasing consumption of products containing ...
(Date:6/27/2016)... ... June 27, 2016 , ... Newly ... technologies, services and solutions to the healthcare market. The company's primary focus is ... manufacturing, sales and marketing strategies that are necessary to help companies efficiently bring ...
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
Breaking Biology Technology: